Skip to main content
OpenTrials

Clinical trial condition

Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Explore clinical trials studying Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma trial results

Recruiting

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

NCT07439653

Conditions
Hemic and Lymphatic Diseases, Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma, Immune System Diseases, +8 more
Locations
  • UCLA Santa Monica, California, United States
  • Stanford University Stanford, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details

Related conditions